First Patients Enrolled in the U.S. OPEN Clinical Trial of the FlexStent(R) Femoropopliteal SE Stent System

Flexible Stenting Solutions Inc. has announced the successful treatment of the first two patients enrolled in the OPEN (Evaluation of Safety and Efficacy of the FlexStent(R) FemorOPopliteal Self-Expanding StENt System) clinical trial.

MAQUET CARDIOVASCULAR RECEIVES FDA 510(K ) CLEARANCE AND CE MARK FOR ITS NEW SENSATION PLUS™INTRA – AORTIC BALLOON CATHETER

MAQUET Cardiovascular has announced that it has received both 510(k) clearance from the U.S. Food & Drug Administration (FDA) and CE mark approval for its new SENSATION PLUS™ 50cc 8 Fr. intra-aortic balloon catheter.

BIOTRONIK Announces Completion of Enrollment in the BIOLUX P-I Clinical Study Investigating Drug-eluting Balloon Therapy for Peripheral Artery Disease

BIOTRONIK has announced the completion of enrollment in the BIOLUX P-I – a clinical study investigating the use of a drug-eluting balloon (DEB) catheter, a promising new approach to treating disease in the more challenging peripheral vascular anatomy.

Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia

Abbott has announced the initiation of ABSORB BTK, an international clinical trial evaluating the safety and efficacy of the ABSORB™ bioresorbable vascular scaffold (BVS) for the treatment of below-the-knee (BTK) critical limb ischemia.